These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 24829938)

  • 1. Lifelong vaccination as a key disease-prevention strategy.
    Bonanni P; Sacco C; Donato R; Capei R
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():32-6. PubMed ID: 24829938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
    Menzies R; Turnour C; Chiu C; McIntyre P
    Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in adult vaccination.
    de Gomensoro E; Del Giudice G; Doherty TM
    Ann Med; 2018 May; 50(3):181-192. PubMed ID: 29338438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosenescence: Implications for vaccination programmes in adults.
    Lang PO; Govind S; Michel JP; Aspinall R; Mitchell WA
    Maturitas; 2011 Apr; 68(4):322-30. PubMed ID: 21316879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
    Sutter RW; Prevots DR; Cochi SL
    Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expanded programme on immunization: a lasting legacy of smallpox eradication.
    Okwo-Bele JM; Cherian T
    Vaccine; 2011 Dec; 29 Suppl 4():D74-9. PubMed ID: 22486980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to the vaccination of children and adolescents and possible solutions.
    Esposito S; Principi N; Cornaglia G;
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():25-31. PubMed ID: 24354949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global routine vaccination coverage, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(44):1520-2. PubMed ID: 22071590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence and vaccination coverage of vaccine-preventable diseases in perinatally HIV-1-infected patients.
    Sticchi L; Bruzzone B; Caligiuri P; Rappazzo E; Lo Casto M; De Hoffer L; Gustinetti G; Viscoli C; Di Biagio A
    Hum Vaccin Immunother; 2015; 11(1):263-9. PubMed ID: 25483544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recognition of the vaccination: a key and important strategy in controlling vaccine preventable diseases].
    Zhou L; Cui FQ; Pan Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):755-758. PubMed ID: 27655592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine-preventable diseases: from paediatric to adult targets.
    Esposito S; Durando P; Bosis S; Ansaldi F; Tagliabue C; Icardi G;
    Eur J Intern Med; 2014 Mar; 25(3):203-12. PubMed ID: 24389370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. State of immunization in the Americas.
    de Quadros CA; Tambini G; DiFabio JL; Brana M; Santos JI
    Infect Dis Clin North Am; 2000 Mar; 14(1):241-57, xi. PubMed ID: 10738681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tdap5 vaccine (Covaxis): a review of its use as a single-booster immunization for the prevention of tetanus, diphtheria, and pertussis in children (aged 4 years), adolescents, and adults.
    Scott LJ
    BioDrugs; 2010 Dec; 24(6):387-406. PubMed ID: 21043546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospects for the eradication of infectious diseases.
    Stuart-Harris C
    Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of surveillance in assuring mutual protection for vaccine-preventable diseases.
    Lopalco PL
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S85-S88. PubMed ID: 27476865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Eradication of infectious diseases by vaccination].
    Saliou P
    Med Trop (Mars); 2007 Aug; 67(4):321-7. PubMed ID: 17926788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015.
    Pezzotti P; Bellino S; Prestinaci F; Iacchini S; Lucaroni F; Camoni L; Barbieri MM; Ricciardi W; Stefanelli P; Rezza G
    Vaccine; 2018 Mar; 36(11):1435-1443. PubMed ID: 29428176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.
    McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M
    Commun Dis Intell; 2000 Jun; Suppl():v-83. PubMed ID: 12049363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.